News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Opinion Editor's Corner Glancing Back, Looking Forward: Lasting Lessons for Years to Come Shelley Wood December 27, 2021
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021
News Daily News New Insights Into Myocarditis and mRNA COVID-19 Vaccines Yael L. Maxwell December 17, 2021
News Features As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years Caitlin E. Cox December 16, 2021
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk Todd Neale December 03, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Conference News AHA 2021 Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded L.A. McKeown November 18, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News TCT 2021 Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More Todd Neale November 04, 2021